CING Cingulate Inc.
$5.02▼ -2.90%
Healthcare
Other
After hours
$5.07▲ +0.90%
Sep 11, 7:30 PM ET
Volume 94.4K
Avg Volume (10D) 107.0K
Key Metrics & Fundamentals
Market Cap
$73.00M
P/E Ratio
–
Div Yield
–%
52W Range
3.16 - 11.89
% vs 50 MA
-0.24%
% vs 200 MA
-5.54%
RSI-14
44.6
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.39
Free Cash Flow
-$5.97M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.00M
COGS
–
Operating Exp
$5.41M
Operating Income
-$5.41M
EBIT
-$5.41M
Pretax Income
-$5.87M
Net Income
-$5.87M
EPS (Diluted)
-0.45
Price & Volume History
Loading chart…
Recent News
CING: Second Quarter Results
Zacks Small Cap Research · Aug 19, 2026 3:13 PM
Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness
GlobeNewswire · Aug 13, 2026 12:30 PM
Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile
GlobeNewswire · Aug 11, 2026 12:30 PM
Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology
GlobeNewswire · Jul 30, 2026 12:30 PM
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
GlobeNewswire · Jul 2, 2026 12:30 PM
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
GlobeNewswire · Jun 16, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CING's money flow as a full page
Social Sentiment
No Reddit posts found for CING.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.